Press Releases

Biocon Biologics  /  Press Releases

Biocon Q3FY25 Revenue at Rs 3,856 Cr, Up 7%# EBITDA at Rs 787 Cr, Up 16%#; Net Profit at Rs 25 Cr

  • Posted by: Biocon Biologics

Biocon’s S&P Global ESG Score Improves to 69 for 2024

  • Posted by: Biocon Biologics

Biocon Biologics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

  • Posted by: Biocon Biologics

Biocon Biologics Completes One Year as an Integrated Global Biosimilars Enterprise

  • Posted by: Biocon Biologics

Kiran Mazumdar-Shaw Honored by ISQ with ‘Jamsetji Tata Award’ for Pioneering Biosciences Movement in India

  • Posted by: Biocon Biologics

Biocon Biologics Recognized as Asia IP Elite for 2024 by IAM, Cementing Leadership in Intellectual Property Excellence

  • Posted by: Biocon Biologics

Biocon Celebrates 46th Founder’s Day with Anthem Launch, Walkathon, Leadership Talk and Experience Center Inauguration

  • Posted by: Biocon Biologics

Biocon Biologics Supports Diabetes Africa to Drive Progress in Embedding Specialist Nurses in Diabetes Care in Ethiopia

  • Posted by: Biocon Biologics

Biocon Academy Achieves 100% Placement within 2.5 hours for Quality Control Analytical Program

  • Posted by: Biocon Biologics

Biocon Q2FY25 Revenue at Rs 3,623 Cr, EBITDA at Rs 718 Cr

  • Posted by: Biocon Biologics
Share
buy twitter followers - omegle - matadorbet güncel adres - onwin - onwin güncel adres